Sotrovimab along with other monoclonal antibodies aid in reducing viral load by interfering with SARS-CoV-2 entry into a cell therefore reducing the likelihood of disease progression to include severe respiratory symptoms and cytokine storm. So they, along with vaccines, help with preventing or reducing the overall severity of the disease. Once the disease however progresses to the stage of severe respiratory distress then these products can not help the patient and they would seem to benefit from steroids and Remestemcel-L. So yes you are correct that less people will end up in the ICU from taking such products, however they are not in direct competition with Remestemcel-L because our therapy is positioned further along the disease progression pathway where they end up in ICUs. There will always be a market for Remestemcel-L because not all therapies will work for all people, not all people can take all therapies, not everyone will get vaccinated or leave it too late once have COVID symptoms and end up in the ICU. This is a good thing IMO preventing people from going to the ICUs, however when they get there with severe respiratory symptoms they we will be there to help them when finally approved. Hope this helps.
- Forums
- ASX - By Stock
- MSB
- New Covid 19 treatment
New Covid 19 treatment, page-4
-
- There are more pages in this discussion • 441 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Featured News
Add MSB (ASX) to my watchlist
(20min delay)
|
|||||
Last
$1.01 |
Change
0.030(3.06%) |
Mkt cap ! $1.153B |
Open | High | Low | Value | Volume |
$1.01 | $1.04 | 99.0¢ | $5.111M | 5.050M |
Buyers (Bids)
No. | Vol. | Price($) |
---|---|---|
2 | 211966 | $1.01 |
Sellers (Offers)
Price($) | Vol. | No. |
---|---|---|
$1.02 | 136540 | 9 |
View Market Depth
No. | Vol. | Price($) |
---|---|---|
1 | 48333 | 1.005 |
3 | 49000 | 1.000 |
3 | 80800 | 0.995 |
5 | 129515 | 0.990 |
1 | 3300 | 0.985 |
Price($) | Vol. | No. |
---|---|---|
1.020 | 136540 | 9 |
1.025 | 63000 | 3 |
1.030 | 28077 | 3 |
1.040 | 27850 | 2 |
1.045 | 103431 | 6 |
Last trade - 16.10pm 16/08/2024 (20 minute delay) ? |
Featured News
MSB (ASX) Chart |